• UCLA Health
  • myUCLAhealth
  • School of Medicine
Office of Compliance Services

Office of Compliance Services

Office of Compliance Services
  • About Our Program
    • Message from the Vice Chancellor
    • Code of Conduct & Statement of Ethics
    • Organizational Structure
    • Contact Us
    • Staff Spotlight
    • Program Description
    • Hotline Information
    • Conflict of Interest/Vendor Relations
    • Other Informative Sites
  • Compliance Services
    • Clinical Research Billing
    • Hospital Compliance
    • Professional Compliance
    • Frequently Asked Questions
    • EMTALA Compliance Program
  • Information Security & Privacy
    • Device Security
    • Additional Resources
    • HIPAA Training
    • Forms
    • Guidance and Policies
    • Frequently Asked Questions
  • Education & Training
    • Clinical Research Compliance Training
    • New and Current Faculty Training
    • EMTALA Training
    • HIPAA Training
    • Ethics Briefing/Conflict of Interest Training
    • Clinical Laboratory and Pathology Compliance Training
    • Advisory Notices
    • Webinars
  • Policies & Procedures
    • Clinical Laboratory and Pathology Compliance
    • Ronald Reagan UCLA Medical Center (Westwood)
    • Resnick Neuropsychiatric Hospital at UCLA
    • UCLA Santa Monica Medical Center
  • Compliance Tips
    • Frequently Asked Questions
    • Information Security Tips
    • Privacy Tips
    • Hospital, Physician, and Clinical Research Tips
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

Office of Compliance Services

Frequently Asked Questions

  1. Home
  2. Frequently Asked Questions

Frequently Asked Questions

Share this

How does the Investigator ensure there is appropriate approval from CMS to bill Medicare for the items/services on the device study protocol?

For Investigator-initiated IDE and non-significant risk device studies, the Investigator will need to work with the Director of Reimbursement for UCLA Medical Financial Services to submit the device study information to local MAC for approval to bill Medicare. For industry-sponsored device studies initiated after January 1, 2015 the sponsor has the obligation to submit centrally to CMS for approval to bill Medicare. The Investigator should initiate this communication early as the approval or denial letter may be needed to complete contract negotiations and coverage analysis certification with the Clinical Trial Administration Office.

Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Compliance Hotline
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth

Learn more about myUCLAhealth